Disc Medicine, Inc. (IRON)
55.74
-0.86
(-1.52%)
USD |
NASDAQ |
Oct 14, 16:00
55.68
-0.06
(-0.11%)
Pre-Market: 20:00
Disc Medicine Market Cap : 2.137B for Oct. 14, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 2.137B |
| October 13, 2026 | 2.170B |
| October 12, 2026 | 2.319B |
| October 09, 2026 | 2.380B |
| October 08, 2026 | 2.330B |
| October 07, 2026 | 2.346B |
| October 06, 2026 | 2.364B |
| October 05, 2026 | 2.428B |
| October 02, 2026 | 2.474B |
| October 01, 2026 | 2.439B |
| September 30, 2026 | 2.510B |
| September 29, 2026 | 2.526B |
| September 28, 2026 | 2.489B |
| September 25, 2026 | 2.502B |
| September 24, 2026 | 2.548B |
| September 23, 2026 | 2.534B |
| September 22, 2026 | 2.626B |
| September 21, 2026 | 2.626B |
| September 18, 2026 | 2.666B |
| September 17, 2026 | 2.653B |
| September 16, 2026 | 2.629B |
| September 15, 2026 | 2.581B |
| September 14, 2026 | 2.643B |
| September 11, 2026 | 2.686B |
| September 10, 2026 | 2.843B |
| Date | Value |
|---|---|
| September 09, 2026 | 2.934B |
| September 08, 2026 | 2.946B |
| September 04, 2026 | 3.038B |
| September 03, 2026 | 3.043B |
| September 02, 2026 | 3.070B |
| September 01, 2026 | 3.017B |
| August 31, 2026 | 3.016B |
| August 28, 2026 | 3.069B |
| August 27, 2026 | 3.165B |
| August 26, 2026 | 3.170B |
| August 25, 2026 | 3.160B |
| August 24, 2026 | 3.104B |
| August 21, 2026 | 3.060B |
| August 20, 2026 | 3.023B |
| August 19, 2026 | 3.080B |
| August 18, 2026 | 3.075B |
| August 17, 2026 | 3.070B |
| August 14, 2026 | 3.023B |
| August 13, 2026 | 3.068B |
| August 12, 2026 | 3.090B |
| August 11, 2026 | 3.114B |
| August 10, 2026 | 3.002B |
| August 07, 2026 | 2.969B |
| August 06, 2026 | 2.969B |
| August 05, 2026 | 3.026B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.998B |
| Agenus, Inc. | 277.00M |
| Amgen, Inc. | 230.36B |
| Anika Therapeutics, Inc. | 271.01M |
| BioCryst Pharmaceuticals, Inc. | 2.055B |
Market Cap Related Metrics
| PEG Ratio | -0.1803 |
| Price to Book Value | 3.318 |
| Price | 55.74 |
| Earnings Yield | -11.80% |
| PEGY Ratio | -0.1803 |